James E ONeill Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for James E ONeill.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of James E ONeill. James E ONeill is a Chief Accounting Officer in Anika Therapeutics, Inc. ($ANIK) and a Principal Accounting Officer in Cerulean Pharma Inc. ($CERU).
Address: C/O ANIKA THERAPEUTICS, INC. 160 NEW BOSTON STREET WOBURN 01801 MA
Companies in which James E ONeill is an Insider
Anika Therapeutics, Inc.
Industry: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
Position of James E ONeill: Chief Accounting Officer
Holdings: 0 shares
Current Value: $0
Latest Transaction: Feb 14 2005
$ANIK Market Capitalization: $733.34M
$ANIK Previous Close: $50.30
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Dare Bioscience, Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of James E ONeill: Principal Accounting Officer
Holdings: 2,098 shares
Current Value: $2,434
Latest Transaction: Jan 09 2017
$DARE Market Capitalization: $36.49M
$DARE Previous Close: $1.16
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Latest Insider Trading Transactions of James E ONeill
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jan 09 2017 | CERU | Cerulean Pharma In ... | ONeill James E | Principal Accountin ... | Option Exercise | A | 0.82 | 50,000 | 41,000 | 50,000 | |
| Jan 09 2017 | CERU | Cerulean Pharma In ... | ONeill James E | Principal Accountin ... | Option Exercise | A | 0.82 | 5,000 | 4,100 | 5,000 | |
| Jan 09 2017 | CERU | Cerulean Pharma In ... | ONeill James E | Principal Accountin ... | Option Exercise | A | 0.82 | 5,000 | 4,100 | 5,000 | |
| Aug 23 2016 | CERU | Cerulean Pharma In ... | ONeill James E | Principal Accountin ... | Option Exercise | A | 1.14 | 50,000 | 57,000 | 50,000 | |
| May 27 2016 | CERU | Cerulean Pharma In ... | ONeill James E | Principal Accountin ... | Grant | A | 2.38 | 1,098 | 2,613 | 2,098 | 1,000 to 2.1 K (+109.80 %) |
| May 27 2016 | CERU | Cerulean Pharma In ... | ONeill James E | Principal Accountin ... | Option Exercise | A | 3.04 | 4,900 | 14,896 | 4,900 | |
| Feb 14 2005 | ANIK | Anika Therapeutics ... | ONeill James E | Chief Accounting Of ... | Option Exercise | A | 8.71 | 6,000 | 52,260 | 6,000 |